Globus Medical Inc
GMED· NYSE
GMEDGlobus Medical Inc
Released Feb 20, 2024, after the close
10-K filed Feb 21, 2024, 52 days after period end · 0001562762-24-000032
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $616.53M | $274.50M | $250.02M | $233.45M |
| Net Income | $15.03M | $50.06M |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| $15.11M |
| $52.96M |
| EPS Diluted | — | — | — | $0.52 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
